{"id":63346,"date":"2021-05-18T16:11:05","date_gmt":"2021-05-18T14:11:05","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/"},"modified":"2025-10-13T15:32:33","modified_gmt":"2025-10-13T13:32:33","slug":"aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/","title":{"rendered":"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO"},"content":{"rendered":"<p><strong>La empresa de biotecnolog\u00eda en fase cl\u00ednica Aelix Therapeutics -con sede en el Parc Cient\u00edfic de Barcelona y especializada en el descubrimiento y desarrollo de inmunoterapias para la infecci\u00f3n por VIH- anuncia hoy el nombramiento de la Dra. Melanie Rolli como CEO, en sustituci\u00f3n de su predecesor, el Dr. Jos\u00e9 Luis Cabero, que deja las tareas ejecutivas en la compa\u00f1\u00eda.<\/strong><\/p>\n<p>El nuevo puesto de la <strong>Dra. Melani Rolli<\/strong> est\u00e1 avalado por su gran experiencia, obtenida tras d\u00e9cadas de trabajo\u00a0 en el sector farmac\u00e9utico. A lo largo de este periodo la Dra Rolli ha desempe\u00f1ado distintos cargos de responsabilidad en Novartis.<\/p>\n<p>\u00abEstoy encantada de unirme a un equipo tan importante y eficiente como este, que ha conseguido alcanzar un hito hist\u00f3rico al transformar con \u00e9xito un concepto biol\u00f3gico en resultados cl\u00ednicos positivos en su primer ensayo. Nuestro objetivo actual es continuar con el progreso del programa y ser capaces de facilitar una innovadora soluci\u00f3n curativa para las personas con VIH\u00bb, afirma la Dra. Rolli.<\/p>\n<p>Este nombramiento llega tras el anuncio, el pasado marzo del 2021, de los importantes resultados obtenidos por la empresa en el ensayo cl\u00ednico AELIX-002 de fase I\/II. Los datos suponen un desarrollo revolucionario dentro del sector y avalan los planes de AELIX para llevar a cabo ensayos de combinaci\u00f3n m\u00e1s amplios.<\/p>\n<p>\u00abNos complace enormemente dar la bienvenida a la Dra. Rolli a nuestro equipo. Tanto su valiosa e inestimable experiencia como sus habilidades clave nos ser\u00e1n de gran ayuda a la hora de alcanzar nuestros objetivos, dirigir nuestro crecimiento y promover el desarrollo de nuestros programas. Estamos deseando adentrarnos en esta nueva etapa bajo el liderazgo de Melanie\u00bb, afirma el Dr. <strong>Thomas Hecht,<\/strong> presidente del Consejo de Administraci\u00f3n de AELIX. \u00abAsimismo, nos gustar\u00eda expresar nuestro m\u00e1s profundo agradecimiento a <strong>Jos\u00e9 Luis Cabero<\/strong> por la excelente direcci\u00f3n durante los \u00faltimos a\u00f1os\u00bb.<\/p>\n<p>El nombramiento de la Dra. Rolli refuerza la estrategia de la compa\u00f1\u00eda de convertirse en una empresa l\u00edder en el tratamiento del VIH mediante el desarrollo de una vacuna terap\u00e9utica efectiva basada en su tecnolog\u00eda HTI.<\/p>\n<p>Los resultados positivos obtenidos en el ensayo cl\u00ednico sirven para respaldar el futuro desarrollo de estrategias de combinaci\u00f3n basadas en la vacuna con HTI que permitan el control del VIH sin necesidad de recurrir a tratamientos continuos con antirretrovirales. AELIX tiene pensado llevar a cabo m\u00faltiples ensayos cl\u00ednicos pr\u00f3ximamente, incluido el estudio de fase II ya en marcha en colaboraci\u00f3n con Gilead Sciences, en el que se combina la vacuna con HTI y el vesatolimod, un agonista del receptor TRL-7.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La empresa de biotecnolog\u00eda en fase cl\u00ednica Aelix Therapeutics -con sede en el Parc Cient\u00edfic de Barcelona y especializada en el descubrimiento y desarrollo de inmunoterapias para la infecci\u00f3n por&#8230;<\/p>\n","protected":false},"author":14,"featured_media":63298,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[],"class_list":["post-63346","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La empresa de biotecnolog\u00eda en fase cl\u00ednica Aelix Therapeutics -con sede en el Parc Cient\u00edfic de Barcelona y especializada en el descubrimiento y desarrollo de inmunoterapias para la infecci\u00f3n por...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-18T14:11:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:32:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"586\" \/>\n\t<meta property=\"og:image:height\" content=\"330\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO\",\"datePublished\":\"2021-05-18T14:11:05+00:00\",\"dateModified\":\"2025-10-13T13:32:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/\"},\"wordCount\":463,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Melanie-Rolli-web.jpg\",\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/\",\"name\":\"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Melanie-Rolli-web.jpg\",\"datePublished\":\"2021-05-18T14:11:05+00:00\",\"dateModified\":\"2025-10-13T13:32:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Melanie-Rolli-web.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/Melanie-Rolli-web.jpg\",\"width\":586,\"height\":330},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/","og_locale":"es_ES","og_type":"article","og_title":"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO - Parc Cient\u00edfic de Barcelona","og_description":"La empresa de biotecnolog\u00eda en fase cl\u00ednica Aelix Therapeutics -con sede en el Parc Cient\u00edfic de Barcelona y especializada en el descubrimiento y desarrollo de inmunoterapias para la infecci\u00f3n por...","og_url":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2021-05-18T14:11:05+00:00","article_modified_time":"2025-10-13T13:32:33+00:00","og_image":[{"width":586,"height":330,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","type":"image\/jpeg"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Ca\u00f1al","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO","datePublished":"2021-05-18T14:11:05+00:00","dateModified":"2025-10-13T13:32:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/"},"wordCount":463,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/","url":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/","name":"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","datePublished":"2021-05-18T14:11:05+00:00","dateModified":"2025-10-13T13:32:33+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2021\/05\/Melanie-Rolli-web.jpg","width":586,"height":330},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/aelix-therapeutics-nombra-a-la-dra-melanie-rolli-como-nueva-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"Aelix Therapeutics nombra a la Dra. Melanie Rolli como nueva CEO"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/63346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=63346"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/63346\/revisions"}],"predecessor-version":[{"id":63348,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/63346\/revisions\/63348"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/63298"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=63346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=63346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=63346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}